AbbVie Broadens Qulipta Migraine Indication As Anti-CGRP Competition Grows

Approval Comes Month After New Pfizer Product

 
• By Mandy Jackson
  
Tired african-american business woman with headache at office, feeling sick at work, copy space
Qulipta cut headache days significantly for chronic migraine sufferers
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip